| APS | antiphospholipid syndrome |
| OAPS | obstetric antiphospholipid antibodies syndrome |
| IUGR | intrauterine growth restriction |
| CAPS | catastrophic antiphospholipid antibodies syndrome |
| SN-APS | seronegative antiphospholipid antibodies syndrome |
| aPL | antiphospholipid antibodies |
| β2-GPI | beta2-glycoprotein I |
| anti-β2GPI DI | anti-beta2-glycoprotein I domain I |
| CL | Cardiolipin |
| PT/PS | prothrombin/phosphatidylserine |
| LBPA | lysobisphosphatidic acid |
| PE | phosphatidylethanolamine |
| TLC | thin layer chromatographic plates |
| PTMs | post-translational modifications |
| ROS | reactive oxygen species |
| ECs | endothelial cells |
| TLR-4 | Toll-like receptor 4 |
| ApoER2 | apolipoprotein E receptor 2 |
| MyD88 | myeloid differentiation factor 88 |
| IRAK | interleukin-1 receptor-associated kinase 1 |
| MAPK | mitogen-activated protein kinase |
| NF-κB | nuclear factor kappa B |
| TF | Tissue Factor |
| V-CAM | vascular cell adhesion molecule-1 |
| I-CAM | intercellular cell adhesion molecule-1 |
| mTOR | mechanistic target of rapamycin |
| NETs | neutrophil extracellular traps |